Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

STRATAFIX sutures for closing cranial and spine surgical wounds

Official title: Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

Run by University of Michigan · NCT07225101 · Data updated 2026-11-12

This project will test STRATAFIX sutures for closing cranial and spine surgical wounds in adults to learn about long-term safety and healing.

More Traumatic Brain Injury trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment160 (estimated)
SponsorUniversity of Michigan
Academic / other
Locations1 site (Lansing, Michigan)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedJune 30, 2026
Study endsDecember 31, 2026
Registry record updatedNovember 5, 2025
Trial IDNCT07225101 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults having cranial or spine neurosurgical procedures (elective or emergency) that require multilayer suture closure and who do not have allergy to suture materials are appropriate candidates.

Probably not a fit

Patients with prior surgical wound dehiscence, active wound infection, or known allergy to the suture materials are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This phase 4 study enrolls adults undergoing elective or emergent cranial or spinal neurosurgery that requires multilayer wound closure and uses STRATAFIX PDS sutures, with Monocryl listed as a comparator. Participants will have their wound outcomes, surgical site infections, dehiscence, and tissue reactions tracked over time to gather long-term safety data. Because STRATAFIX is already FDA-approved, the focus is on real-world performance in neurosurgical applications rather than initial efficacy. Collected information will inform best practices for wound closure in brain and spine procedures.

Why it matters

Potential benefit: If successful, the study could show STRATAFIX provides reliable long-term wound closure with low rates of infection and dehiscence for neurosurgical patients.

How similar studies have gone: STRATAFIX is FDA-approved and has shown good performance for soft-tissue closure in other surgical specialties, but neurosurgery-specific long-term comparative data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Elective or emergent surgical approaches for cranial or spine neurosurgical approaches, requiring sutures for wound closure, requiring multilayer wound closure

Exclusion Criteria:

* Patients with prior surgical wound dehiscence or infection
* Patients with allergy to suture material

Where it's running

  • University of Michigan Health Sparrow
    Lansing, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.